AC IMMUNE SA SF-02 Long-term Investment Intensity
AC IMMUNE SA SF-02 long-term investment intensity. AC IMMUNE SA SF-02 (IMR) has a Long-term Investment Intensity of 0.4% as of June 2026. Long-term investments of €585.00K represent 0.4% of total assets of €150.40 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read how much debt does AC IMMUNE SA SF-02 carry for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of AC IMMUNE SA SF-02 (2021–2025)
Long-term investment intensity of AC IMMUNE SA SF-02 from 2021 to 2025. This chart shows how AC IMMUNE SA SF-02's Long-term Investment Intensity has evolved across 5 annual periods from 2021 to 2025. As of June 2026, the intensity stands at 0.4%, reflecting long-term investments of €585.00K against total assets of €150.40 Million EUR.
AC IMMUNE SA SF-02 Long-term Investment Intensity by Year (2021–2025)
AC IMMUNE SA SF-02 long-term investment intensity by year from 2021 to 2025. The table below presents the year-by-year Long-term Investment Intensity for AC IMMUNE SA SF-02 from 2021 to 2025, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see IMR total assets.
| Year | LT Investment Intensity | LT Investments (EUR) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2025 | 0.4% | €584.00K | €154.25 Million | ▲ +0.2 pp |
| 2024 | 0.2% | €415.00K | €230.91 Million | ▼ 0.0 pp |
| 2023 | 0.2% | €361.00K | €182.81 Million | ▲ +0.0 pp |
| 2022 | 0.2% | €361.00K | €185.94 Million | ▲ +0.1 pp |
| 2021 | 0.1% | €363.00K | €261.44 Million | — |